New solid modifications of nateglinide

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 5, 2010, Pages 1054-1059

  Bruni, G ^a   Berbenni, V ^a   Milanese, C ^a   Girella, A ^a   Cardini, A ^b   Lanfranconi, S ^b   Marini, A ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b AMSA SpA   (Italy)

Author keywords

DSC; Hemihydrate form; Nateglinide; Physico chemical characterization; Polymorphism; Pseudo polymorphism

Indexed keywords

NATEGLINIDE;

ARTICLE; CRYSTALLIZATION; DRUG FORMULATION; DRUG STORAGE; HUMIDITY; HYDRATION; MELTING POINT; PRIORITY JOURNAL; SPECTROSCOPY; STORAGE TEMPERATURE; THERMAL ANALYSIS; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; CYCLOHEXANES; DRUG STABILITY; DRUG STORAGE; HUMIDITY; HYPOGLYCEMIC AGENTS; PHENYLALANINE; POWDER DIFFRACTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; THERMOGRAVIMETRY; TRANSITION TEMPERATURE; WATER;

EID: 72749112755     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.11.019     Document Type: Article

References (7)

1. Marini A., Berbenni V., Bruni G., Margheritis C., and Orlandi A. J. Pharm. Sci. 90 (2001) 2131-2140
2. Marini A., Berbenni V., Bruni G., Sinistri C., Maggioni A., Orlandi A., and Villa M. J. Pharm. Sci. 89 (2000) 232-240
3. Hilfiker R. Polymorphism in the Pharmaceutical Industry (2006), Wiley-VCH (chapters 1 and 2)
4. Lieder T.R. Am. J. Health Syst. Pharm. 58 (2001) 285-288
5. Li G., Xu Q.W., Mo X.Y., Chen J.Y., and Su G.Q. Chin. Chem. Lett. 14 (2003) 730-733
6. Bruni G., Berbenni V., Milanese C., Girella A., Cardini A., Viganò E., Lanfranconi S., and Marini A. J. Pharm. Biomed. Anal. 50 (2009) 764-770
7. United States Patent, Patent Number: 5,463,116, 1995.